𝐏𝐫𝐢𝐜𝐞 𝐖𝐚𝐭𝐜𝐡™ provides price assessments for Vitamin B3 (Niacin) across top trading regions:
Asia-Pacific
- Vitamin B3 (Niacin) Nicotinamide (>99%) (Powder) FOB Shanghai, China
- Vitamin B3 (Niacin) Nicotinamide (>99%) (Powder) Ex-Zhejiang, China
- Vitamin B3 (Niacin) Nicotinamide (>99%) (Powder) Ex-Mumbai, India
- Vitamin B3 (Niacin) Nicotinamide (>99%) (Powder) CIF Nhava Sheva (China), India
Note: In assessments structured as CIF [Importing Port] (Exporting Country), the country mentioned in brackets indicates the primary origin of supply (exporting country), while the named port refers to the destination port in the importing country. Other Incoterms (FOB, FD, EXW, etc.) should be interpreted in accordance with standard international trade definitions.
Vitamin B3 (Niacin) Price Trend Q4 2025
In Q4 2025, the Vitamin B3 (Niacin) Nicotinamide market in China and India remained largely stable, with prices moving within a narrow range amid balanced supply and subdued downstream demand. Market dynamics in both countries were supported by steady operating rates and comfortable inventory levels, while procurement from the pharmaceutical, nutraceutical, and food-fortification sectors stayed cautious. In China, prices declined within the 0-1% quarter-on-quarter range due to muted domestic consumption and limited export activity. Similarly, in India, prices eased within the 0-1% range reflecting measured trading sentiment and competitive pricing across the broader Asian market. Overall, both markets remained range-bound during the quarter, as the absence of supply disruptions or significant cost pressures prevented any sharp directional shift in pricing.
China: Vitamin B3 (Niacin) Export prices FOB Shanghai, China, Nicotinamide (>99%) (Powder)
In Q4 2025, Vitamin B3 (Niacin) Nicotinamide (>99%) (Powder) prices in China showed marginal softening, reflecting muted downstream demand and steady domestic supply. Prices registered a 0.43% quarter-on-quarter decline. Procurement from pharmaceutical, nutrition and food-fortification sectors remained slow while adequate inventories and stable operating rates across major manufacturers limited price recovery. Export demand also remained modest adding to the subdued market tone. Overall, the market stayed range-bound through the quarter with no clear demand-side trigger to drive a directional shift in pricing in the near term. Despite ongoing supply-side pressure, the absence of aggressive destocking or significant cost volatility helped keep prices largely range bound.
India: Vitamin B3 (Niacin) Domestically Traded prices Ex-Mumbai, India, Nicotinamide (>99%) (Powder)
In Q4 2025, domestic prices of Vitamin B3 (Niacin) in India for Nicotinamide (>99%) powder remained largely steady averaging USD 5,020-5,045 per metric ton and recording a marginal quarter-on-quarter decline of 0.62%. The slight correction reflected balanced supply conditions and stable production levels which were broadly aligned with moderate demand from the pharmaceutical and nutraceutical sectors. Comfortable inventory availability and cautious purchasing kept trading activity measured, while competitive pricing across the wider Asian market prevented any notable upside. Production operations remained consistent throughout the quarter, ensuring uninterrupted supply. Overall sentiment stayed neutral to slightly soft, with prices expected to move within a narrow range unless supported by stronger downstream demand or shifts in upstream cost dynamics in the coming months.

